...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Upcoming Events
 
Bio Europe, March 25-27, 2019. Vienna, Austria. Zenith presents 11 AM local time on March 27 according to Zenith Website. Resverlogix is on list of presenters too, but I couldn't find a listed day/time.
 
American Association for Cancer Research (AACR) March 29 to April 3, 2019. Zenith presenting a poster (see here) on April 1. 
 
American Society of Clinical Oncology (ASCO), May 31 to June 4, 2019. Zenith website indicates they are attending and participating, but I couldn't find them in a program search.

 

Share
New Message
Please login to post a reply